Tissue Eosinophil Counts: A Promising Marker for Optimizing Omalizumab Treatment in Bullous Pemphigoid. Akin G, Akarsu S, Avci C, Lebe B, et al. J Dermatol 2025;52:1691-1697.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Akin G, Akarsu S, Avci C, Lebe B, et al. Tissue Eosinophil Counts: A Promising Marker for Optimizing Omalizumab Treatment in Bullous Pemphigoid. J Dermatol 2025;52:1691-1697.
PMID: 40873247